Edited By : Savannah Pittle
This page features 9 Cited Research Articles
Fact Checked
Fact-Checked

Editors carefully fact-check all Consumer Notice, LLC content for accuracy and quality.

Consumer Notice, LLC has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Latest NEC Baby Formula Lawsuit Updates

As of November 2024, there were 624 active baby formula necrotizing enterocolitis lawsuits pending in MDL 3026 before U.S. District Judge Rebecca Pallmeyer in the Northern District of Illinois.

While there are still no approved settlements or jury verdicts in the Illinois MDL, a state court case in Illinois ended in a $60 million plaintiff’s verdict in March 2024, and in July 2024, a Missouri jury awarded $495 million to NEC baby formula plaintiffs. An October 2024 trial in Missouri ended in a win for the defendants.

A trial schedule proposed in October has the first bellwether trial starting on May 5, 2025.

Baby Formula Litigation Timeline
  • October 2024:
    Abbott and Mead Johnson have prevailed in the latest baby formula state trial. A St. Louis jury opted to side with the defendants in the case, where the mother of a baby who developed NEC had claimed the companies failed to warn of the risk of the serious intestinal disease. This breaks what had been a win streak for plaintiffs in state court, with two huge verdicts awarded earlier this year.

    Meanwhile in the MDL, the parties have reached an agreement on a bellwether trial date proposal, with the first case set to go to trial on May 5, 2025. Judge Pallmeyer will need to approve the proposal, which has the four cases running through February 2026.
  • September 2024:
    The trial order has been set for the four upcoming bellwether cases, with Ericka Mar, as Administratrix of the Estate of RaiLee Mar v. Abbott Laboratories set to go to trial first. Judge Pallmeyer has directed counsel to set firm trial dates for these cases.
  • July 2024:
    A Missouri jury awarded $495 million to the family of an infant who suffered serious complications from NEC after ingesting Abbott's premature infant formula in the NICU. Lawyers are saying this verdict could still influence the course of all baby formula litigation moving forward. The award was made up of $95 million in damages and $400 million in punitive damages. Abbott has said they disagree with the verdict and will try to have it overturned. This was a state court case, and bellwether trials in the federal MDL cases should start in May 2025 if defendants don't try to negotiate a settlement before then.
  • June 2024:
    This month, Judge Pallmeyer released a scheduling order, and we finally had an idea of when the first bellwether test trial could take place. According to the order, the first bellwether test trial will be in May 2025. Even if this bellwether is the first in the MDL, an Illinois jury trial ended in a $60 million verdict for a mother who lost her child to NEC.
  • May 2024:
    MDL Judge Pallmeyer ordered that plaintiffs must have specific evidence that an infant ingested a Mead Johnson product before naming the company as a defendant in the litigation. Evidence may include medical and feeding records from birth.
  • March 2024:
    An Illinois jury ruled that Mead Johnson, a subsidiary of Reckitt Benckiser, must compensate the mother of a premature infant who died from an intestinal disease after being given the company's baby formula, Enfamil, with a verdict of $60 million.
  • February 2024:
    Judge Rebecca Pallmeyer scheduled hearings that involved several plaintiffs on sealed/private motions for March 2024.
  • December 2023:
    Four bellwether cases had been selected, but the start dates for the trials weren't confirmed. Lawyers expected the first trials might happen in 2024.
  • November 2023:
    On Nov. 3, 2023, Justice Pallmeyer signed an order noting that Mead Johnson’s motions to dismiss were entered and continued for briefing. The plaintiffs’ responses had to be filed on or before Jan. 6, 2024.
  • October 2023:
    The judge signed an order outlining the definition of terms and procedures the plaintiffs and defendants agreed to for how NEC pathology reports and expert analysis would be handled.
  • July 2023:
    Judge Pallmeyer held a status conference.
  • April 2023:
    Lawyers were negotiating how discovery should proceed.
  • March 2023:
    Science Day was scheduled for May 3, 2023. Both sides present the science of NEC and its link to cow’s milk baby formula before the court.
  • August 2022:
    The Judicial Panel for Multidistrict Litigation consolidated about 97 lawsuits over NEC claims in Illinois MDL 3026.

Judge Matthew Kennelly presides over a separate Abbott MDL, no. 3037. This MDL is also in Illinois and is related to bacterial contamination of Abbott’s baby formulas. It does not have anything to do with NEC claims.

Why are Parents Filing Similac and Enfamil Lawsuits?

NEC baby formula lawsuits are claims parents filed because infants developed necrotizing enterocolitis after consuming Similac or Enfamil cow’s milk baby formula. Necrotizing enterocolitis, or NEC, is a serious gastrointestinal disease that causes intestinal tissue death and could lead to serious health problems or death.

Studies have shown premature babies fed cow’s milk baby formula have an increased risk of developing NEC. An NEC lawsuit for baby formula claims baby formula makers Abbott and Mead Johnson knew about the risk but failed to warn the public and continued to sell the dangerous products.

In April 2022, judges consolidated Similac and Enfamil lawsuits from across the country into multidistrict litigation in the Northern District of Illinois under MDL number 3026.

These cases all claim that “cow’s milk-based infant formula products marketed under the Similac and Enfamil brand names have a higher propensity to cause necrotizing enterocolitis (NEC) in infants born prematurely than other, allegedly safer alternatives,” according to the case transfer order.

Who Qualifies To File an NEC Baby Formula Lawsuit?

Parents or caregivers of premature babies who developed NEC after consuming Similac or Enfamil cow’s milk baby formulas may qualify to file an NEC baby formula lawsuit.

Babies may have consumed Similac or Enfamil in the hospital. Parents may have taken formula from the hospital or bought formula after bringing their preemie home.

Lawyers encourage parents and caregivers to keep all medical records, receipts and formula packaging for evidence in their case. If you don’t know if your baby was fed Similac or Enfamil, your lawyer may be able to help get this information.

How Much Will Baby Formula Lawsuits Be Worth?

The exact worth of Enfamil and Similac baby formula lawsuits has yet to be determined, though lawyers speculate the value could be in the millions. But in March 2024, a state court jury in Illinois awarded $60 million to a mother who lost her child after the infant developed NEC following feeding with Enfamil.

It’s important to note that parents and caregivers don’t have any guarantee of receiving a specific amount of compensation. The severity of injuries, cost of financial or physical damages and other losses may influence how much a baby formula case is worth.

After the first bellwether cases happen in 2025, lawyers will have a better idea of how much baby formula cases could be worth. Jury verdicts after bellwether trials could lead to global baby formula settlements.

Similac and Enfamil Baby Formula Recalls

Similac and Enfamil baby formulas have not been recalled for NEC. However, Abbott issued a baby formula recall for potential bacterial contamination in February 2022 after some babies died from infections.

The recall included certain lots of EleCare, Similac and Alimentum baby formulas from Abbott’s factory in Sturgis, Michigan. The U.S. Food and Drug Administration found several strains of Cronobacter sakazakii at the plant during its March 2022 inspection, but it didn’t find any bacteria in product samples.

Cronobacter can cause serious illness in infants, including death. Symptoms of Cronobacter infection include jaundice, irritability, temperature changes, grunting breaths, poor feeding and excessive crying. Contact your child’s physician right away if you suspect infection.

Parents can see if their formula is included in the recall by entering lot numbers on Abbott’s recall website.

Please seek the advice of a qualified professional before making decisions about your health or finances.
Last Modified: November 1, 2024

9 Cited Research Articles

Consumernotice.org adheres to the highest ethical standards for content production and references only credible sources of information, including government reports, interviews with experts, highly regarded nonprofit organizations, peer-reviewed journals, court records and academic organizations. You can learn more about our dedication to relevance, accuracy and transparency by reading our editorial policy.

  1. United States Judicial Panel on Multidistrict Litigation. (2024, November 1). MDL Statistics Report - Distribution of Pending MDL Dockets by District. Retrieved from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-November-1-2024_0.pdf
  2. United States District Court for the Northern District of Illinois, Eastern Division. (2024, October 4). Stipulation Regarding Proposed Trial Dates. Retrieved from https://ecf.ilnd.uscourts.gov/doc1/067131234295
  3. Pierson, B. & Knauth, D. (2024, July 26). Abbott must pay $495 million in premature infant formula trial, jury finds. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-must-pay-95-million-premature-infant-formula-trial-jury-finds-2024-07-26/
  4. Centers for Disease Control and Prevention. (2024). Cronobacter and Powdered Infant Formula Investigation. Retrieved from https://www.cdc.gov/cronobacter/outbreaks/source-date/index.html
  5. U.S. District Court of the Northern District of Illinois. (2023, November 3). Order to Dismiss. Retrieved from http://www.pacer.gov
  6. U.S. District Court of the Northern District of Illinois. (2023, October). Order Regarding Pathology. Retrieved from http://www.pacer.gov
  7. Abbott Laboratories. (2022, August 26). Abbott is Restarting Similac Production at Sturgis. Retrieved from https://www.abbott.com/corpnewsroom/nutrition-health-and-wellness/abbott-update-on-powder-formula-recall.html
  8. U.S. Food and Drug Administration. (2022, August 1). FDA Investigation of Cronobacter Infections: Powdered Infant Formula. Retrieved from https://www.fda.gov/food/outbreaks-foodborne-illness/fda-investigation-cronobacter-infections-powdered-infant-formula-february-2022
  9. Reuters. (2022, June 22). FDA Gets Complaint of One More Infant Death Related to Baby Formula. Retrieved from https://www.foxbusiness.com/politics/fda-complaint-one-more-infant-death-related-baby-formula